Outpatient Surgery Magazine

The Trouble With Transvaginal Mesh - August 2016 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/713724

Contents of this Issue

Navigation

Page 80 of 128

astroesophageal reflux disease (GERD) leaves a bad taste in millions of mouths every day. The large number of suf- ferers (estimates range as high as 30% of the U.S. popula- tion), combined with growing concerns about the medica- tions traditionally used to treat it (see "Serious Side Effects of Proton Pump Inhibitors" on page 52), are creating a huge potential market for minimally invasive surgical and endoscopic procedures. Here's a look at 5 promising new approaches the FDA has either recently approved or is likely to in the next few years. Stretta Approved by the FDA in 2000, Stretta (marketed by Mederi G 1 A U G U S T 2 0 1 6 • O U T PA T I E N TS U R G E R Y. N E T • 8 1 New Technologies for Treating GERD 5 The list of minimally invasive surgical and endoscopic options is expanding. Ronnie Fass, MD Cleveland, Ohio • HELP ON THE WAY Several promising technologies for treating GERD have either recently been approved by the FDA, or likely will be in the next few years.

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - The Trouble With Transvaginal Mesh - August 2016 - Subscribe to Outpatient Surgery Magazine